Skip to main content

MARSHALL WACE, LLP

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,427,015
+$882,659 QoQ
Shares Held
232,919
-7.2% QoQ
Ownership
0.770%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 95 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. RNAC ranks #135 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RNAC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,427,015 232,919
2026-03-31 $1,544,356 251,115
2025-12-31 $1,284,389 178,140
2025-09-30 $866,716 84,806
2025-06-30 $858,525 82,630
2025-03-31 $508,813 38,605
2024-06-30 $811,325 30,038
2023-03-31 $1,805,263 1,298,751
2022-12-31 $1,480,800 1,310,443
2022-09-30 $3,032,474 1,849,070
2022-06-30 $1,287,318 982,686
2022-03-31 $626,424 509,288
2021-12-31 $6,492,576 1,991,588
2021-06-30 $1,271,961 304,297
2020-09-30 $2,537,178 1,023,056